CoChat

PET Imaging Unveils Neuroinflammatory Mechanisms in Psychiatric Disorders: From Microglial Activation to Therapeutic Innovation

Liu, Yu-dan, Chang, Yi-heng, Xie, Xue-ting, Wang, Xin-yao, Ma, Hao-yan, Liu, Mei-chen, Zhang, Hui-min · 2025 · Molecular Neurobiology
Cited by 27

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12035-025-05177-w

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Research works printed but not linked: 126

  1. Zhang L, Hu K, Shao T, Hou L, Zhang S, Ye W et al (2021) Recent developments on PET radiotracers for TSPO and their applications in neuroimaging. Acta Pharm Sin B 11:373–393 · DOI · Paper page
  2. Beurel E, Toups M, Nemeroff CB (2020) The bidirectional relationship of depression and inflammation: double trouble. Neuron 107:234–256 · DOI · Paper page
  3. Ransohoff RM, Perry VH (2009) Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 27:119–145 · DOI · Paper page
  4. Boche D, Perry VH, Nicoll JAR (2013) Review: Activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol 39:3–18 · DOI · Paper page
  5. Hu X, Li P, Guo Y, Wang H, Leak RK, Chen S et al (2012) Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43:3063–3070 · DOI · Paper page
  6. Galea I (2021) The blood–brain barrier in systemic infection and inflammation. Cell Mol Immunol 18:2489–2501 · DOI · Paper page
  7. Cheng Y, Desse S, Martinez A, Worthen RJ, Jope RS, Beurel E (2018) TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice. Brain Behav Immun 69:556–567 · DOI · Paper page
  8. Kamintsky L, Cairns KA, Veksler R, Bowen C, Beyea SD, Friedman A et al (2020) Blood-brain barrier imaging as a potential biomarker for bipolar disorder progression. Neuroimage Clin; 26. · DOI
  9. Medina-Rodriguez EM, Beurel E (2022) Blood brain barrier and inflammation in depression. Neurobiol Dis; 175 · DOI · Paper page
  10. Meyer JH, Cervenka S, Kim M-J, Kreisl WC, Henter ID, Innis RB (2020) Neuroinflammation in psychiatric disorders: PET imaging and promising new targets. Lancet Psychiatry 7:1064–1074 · DOI · Paper page
  11. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapère J-J, Lindemann P et al (2006) Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27:402–409 · DOI · Paper page
  12. Attwells S, Setiawan E, Rusjan PM, Xu C, Hutton C, Rafiei D et al (2020) Translocator protein distribution volume predicts reduction of symptoms during open-label trial of celecoxib in major depressive disorder. Biol Psychiatry 88:649–656 · DOI
  13. Papadopoulos V, Liu J, Culty M (2007) Is there a mitochondrial signaling complex facilitating cholesterol import? Mol Cell Endocrinol 265–266:59–64 · DOI
  14. Papadopoulos V (2014) On the role of the translocator protein (18-kDa) TSPO in steroid hormone biosynthesis. Endocrinology 155:15–20 · DOI · Paper page
  15. Miller WL (2013) Steroid hormone synthesis in mitochondria. Mol Cell Endocrinol 379:62–73 · DOI · Paper page
  16. Morohaku K, Pelton SH, Daugherty DJ, Butler WR, Deng W, Selvaraj V (2014) Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. Endocrinology 155:89–97 · DOI · Paper page
  17. Levin E, Premkumar A, Veenman L, Kugler W, Leschiner S, Spanier I et al (2005) The peripheral-type benzodiazepine receptor and tumorigenicity: isoquinoline binding protein (IBP) antisense knockdown in the C6 glioma cell line. Biochemistry 44:9924–9935 · DOI
  18. Kletsas D, Li W, Han Z, Papadopoulos V (2004) Peripheral-type benzodiazepine receptor (PBR) and PBR drug ligands in fibroblast and fibrosarcoma cell proliferation: role of ERK, c-Jun and ligand-activated PBR-independent pathways. Biochem Pharmacol 67:1927–1932 · DOI
  19. Li W, Hardwick MJ, Rosenthal D, Culty M, Papadopoulos V (2007) Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation. Biochem Pharmacol 73:491–503 · DOI
  20. Zeno S, Zaaroor M, Leschiner S, Veenman L, Gavish M (2009) CoCl(2) induces apoptosis via the 18 kDa translocator protein in U118MG human glioblastoma cells. Biochemistry 48:4652–4661 · DOI · Paper page
  21. Gavish M, Veenman L (2018) Regulation of mitochondrial, cellular, and organismal functions by TSPO. In: Apprentices to genius: a tribute to Solomon H. Snyder p103–36 · DOI
  22. Gatliff J, Campanella M (2015) TSPO is a REDOX regulator of cell mitophagy. Biochem Soc Trans 43:543–552 · DOI
  23. Khalil B, El Fissi N, Aouane A, Cabirol-Pol MJ, Rival T, Liévens JC (2015) PINK1-induced mitophagy promotes neuroprotection in Huntington’s disease. Cell Death Dis 6:e1617 · DOI · Paper page
  24. Klinedinst NJ, Regenold WT (2014) A mitochondrial bioenergetic basis of depression. J Bioenerg Biomembr 47:155–171 · DOI
  25. Kuffner K, Triebelhorn J, Meindl K, Benner C, Manook A, Sudria-Lopez D et al (2018) Major depressive disorder is associated with impaired mitochondrial function in skin fibroblasts. Cells 9 · DOI
  26. Ransohoff RM, Schafer D, Vincent A, Blachère NE, Bar-Or A (2015) Neuroinflammation: ways in which the immune system affects the brain. Neurotherapeutics 12:896–909 · DOI · Paper page
  27. Qin L, Xiao L, Zhu H, Du Y, Tang Y, Feng L (2024) Translocator protein (18 kDa) positron emission tomography imaging as a biomarker of neuroinflammation in epilepsy. Neurol Sci 45:5201–5211 · DOI
  28. Maeng SH, Hong H (2019) Inflammation as the potential basis in depression. Int Neurourol J 23:S63-71 · DOI
  29. Lavisse S, Guillermier M, Hérard A-S, Petit F, Delahaye M, Van Camp N et al (2012) Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J Neurosci 32:10809–10818 · DOI · Paper page
  30. Rupprecht R, Wetzel CH, Dorostkar M, Herms J, Albert NL, Schwarzbach J et al (2022) Translocator protein (18kDa) TSPO: a new diagnostic or therapeutic target for stress-related disorders? Mol Psychiatry 27:2918–2926 · DOI
  31. Chauveau F, Boutin H, Van Camp N, Dollé F, Tavitian B (2008) Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. Eur J Nucl Med Mol Imaging 35:2304–2319 · DOI · Paper page
  32. Dollé F, Luus C, Reynolds A, Kassiou M (2009) Radiolabelled molecules for imaging the translocator protein (18 kDa) using positron emission tomography. Curr Med Chem 16:2899–2923 · DOI · Paper page
  33. Tang D, McKinley ET, Hight MR, Uddin MI, Harp JM, Fu A et al (2013) Synthesis and structure-activity relationships of 5,6,7-substituted pyrazolopyrimidines: discovery of a novel TSPO PET ligand for cancer imaging. J Med Chem 56:3429–3433 · DOI
  34. Scarf AM, Ittner LM, Kassiou M (2009) The translocator protein (18 kDa): central nervous system disease and drug design. J Med Chem 52:581–592 · DOI · Paper page
  35. Imaizumi M, Kim HJ, Zoghbi SS, Briard E, Hong J, Musachio JL et al (2007) PET imaging with [11C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat. Neurosci Lett 411:200–205 · DOI · Paper page
  36. Zhang MR, Kida T, Noguchi J, Furutsuka K, Maeda J, Suhara T et al (2003) [(11)C]DAA1106: radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brain. Nucl Med Biol 30:513–519 · DOI · Paper page
  37. Ikawa M, Lohith TG, Shrestha S, Telu S, Zoghbi SS, Castellano S et al (2017) 11C-ER176, a radioligand for 18-kDa translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain. J Nucl Med 58:320–325 · DOI · Paper page
  38. Fan Z, Calsolaro V, Atkinson RA, Femminella GD, Waldman A, Buckley C et al (2016) Flutriciclamide (18F-GE180) PET: first-in-human PET study of novel third-generation in vivo marker of human translocator protein. J Nucl Med 57:1753–1759 · DOI · Paper page
  39. Setiawan E, Attwells S, Wilson AA, Mizrahi R, Rusjan PM, Miler L et al (2018) Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study. Lancet Psychiatry 5:339–347 · DOI · Paper page
  40. James ML, Selleri S, Kassiou M (2006) Development of ligands for the peripheral benzodiazepine receptor. Curr Med Chem 13:1991–2001 · DOI · Paper page
  41. Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3:e442 · DOI · Paper page
  42. Afridi R, Suk K (2021) Neuroinflammatory basis of depression: learning from experimental models. Front Cell Neurosci 15 · DOI · Paper page
  43. Richards EM, Zanotti-Fregonara P, Fujita M, Newman L, Farmer C, Ballard ED et al (2018) PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects. EJNMMI Res 8 · DOI · Paper page
  44. Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G et al (2015) Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry 72 · DOI · Paper page
  45. Li H, Sagar AP, Kéri S (2018) Translocator protein (18 kDa TSPO) binding, a marker of microglia, is reduced in major depression during cognitive-behavioral therapy. Prog Neuro-Psychopharmacol Biol Psychiatry 83:1–7 · DOI
  46. Li H, Sagar AP, Kéri S (2018) Microglial markers in the frontal cortex are related to cognitive dysfunctions in major depressive disorder. J Affect Disord 241:305–310 · DOI · Paper page
  47. Holmes SE, Hinz R, Conen S, Gregory CJ, Matthews JC, Anton-Rodriguez JM et al (2018) Elevated translocator protein in anterior cingulate in major depression and a role for inflammation in suicidal thinking: a positron emission tomography study. Biol Psychiatry 83:61–69 · DOI · Paper page
  48. Su L, Faluyi YO, Hong YT, Fryer TD, Mak E, Gabel S et al (2016) Neuroinflammatory and morphological changes in late-life depression: the NIMROD study. Br J Psychiatry 209:525–526 · DOI · Paper page
  49. Joo Y-H, Lee M-W, Son Y-D, Chang K-A, Yaqub M, Kim H-K et al (2021) In vivo cerebral translocator protein (TSPO) binding and its relationship with blood adiponectin levels in treatment-naïve young adults with major depression: a [11C]PK11195 PET study. Bio 10 · DOI
  50. Schubert JJ, Veronese M, Fryer TD, Manavaki R, Kitzbichler MG, Nettis MA et al (2021) A modest increase in 11C-PK11195-positron emission tomography TSPO binding in depression is not associated with serum C-reactive protein or body mass index. Biol Psychiatry Cogn Neurosci Neuroimaging 6:716–724
  51. Gędek A, Szular Z, Antosik AZ, Mierzejewski P, Dominiak M (2023) Celecoxib for mood disorders: a systematic review and meta-analysis of randomized controlled trials. J Clin Med 12 · DOI
  52. Zazula R, Husain MI, Mohebbi M, Walker AJ, Chaudhry IB, Khoso AB et al (2020) Minocycline as adjunctive treatment for major depressive disorder: pooled data from two randomized controlled trials. Aust N Z J Psychiatry 55:784–798 · DOI · Paper page
  53. Riebel M, Brunner L-M, Nothdurfter C, Wein S, Schwarzbach J, Liere P et al (2024) Neurosteroids and translocator protein 18 kDa (TSPO) ligands as novel treatment options in depression. Eur Arch Psychiatry Clin Neurosci · DOI
  54. Bhandage AK, Jin Z, Korol SV, Shen Q, Pei Y, Deng Q et al (2018) GABA regulates release of inflammatory cytokines from peripheral blood mononuclear cells and CD4+ T cells and is immunosuppressive in type 1 diabetes. EBioMedicine 30:283–294 · DOI · Paper page
  55. Kim JK, Kim YS, Lee H-M, Jin HS, Neupane C, Kim S et al (2018) GABAergic signaling linked to autophagy enhances host protection against intracellular bacterial infections. Nat Commun 9 · DOI · Paper page
  56. Tovar-Gudiño E, Guevara-Salazar JA, Bahena-Herrera JR, Trujillo-Ferrara JG, Martínez-Campos Z, Razo-Hernández RS et al (2018) Novel-substituted heterocyclic GABA analogues. Enzymatic activity against the GABA-AT enzyme from Pseudomonas fluorescens and in silico molecular modeling. Molecules 23 · DOI
  57. Bannister E (2019) There is increasing evidence to suggest that brain inflammation could play a key role in the aetiology of psychiatric illness. Could inflammation be a cause of the premenstrual syndromes PMS and PMDD? Post Reprod Health 25:157–61 · DOI
  58. Bäckström T, Doverskog M, Blackburn TP, Scharschmidt BF, Felipo V (2024) Allopregnanolone and its antagonist modulate neuroinflammation and neurological impairment. Neurosci Biobehav Rev 161 · DOI
  59. Coirini H, Rey M (2015) Synthetic neurosteroids on brain protection. Neural Regen Res 10 · DOI
  60. Eser D, Romeo E, Baghai TC, Schüle C, Zwanzger P, Rupprecht R (2006) Neuroactive steroids as modulators of depression and anxiety. Expert Rev Endocrinol Metab 1:517–526 · DOI
  61. Zorumski CF, Paul SM, Izumi Y, Covey DF, Mennerick S (2013) Neurosteroids, stress and depression: potential therapeutic opportunities. Neurosci Biobehav Rev 37:109–122 · DOI · Paper page
  62. Meshkat S, Teopiz KM, Di Vincenzo JD, Bailey JB, Rosenblat JD, Ho RC et al (2023) Clinical efficacy and safety of Zuranolone (SAGE-217) in individuals with major depressive disorder. J Affect Disord 340:893–898 · DOI
  63. Barron AM, Higuchi M, Hattori S, Kito S, Suhara T, Ji B (2020) Regulation of anxiety and depression by mitochondrial translocator protein-mediated steroidogenesis: the role of neurons. Mol Neurobiol 58:550–563 · DOI
  64. Ren P, Ma L, Wang J-Y, Guo H, Sun L, Gao M-L et al (2020) Anxiolytic and anti-depressive like effects of translocator protein (18 kDa) ligand YL-IPA08 in a rat model of postpartum depression. Neurochem Res 45:1746–1757 · DOI
  65. Nozaki K, Ito H, Ohgidani M, Yamawaki Y, Sahin EH, Kitajima T et al (2020) Antidepressant effect of the translocator protein antagonist ONO-2952 on mouse behaviors under chronic social defeat stress. Neuropharmacology 162 · DOI
  66. Dean SL, Singer HS (2017) Treatment of Sydenham’s chorea: a review of the current evidence. Tremor Other Hyperkinet Mov (N Y) 7:456 · DOI
  67. Meyer J (2021) Inflammation, obsessive-compulsive disorder, and related disorders. In: The neurobiology and treatment of OCD: accelerating progress. Chap 210:p31–53 · DOI
  68. Alonso P, López-Solà C, Real E, Segalàs C, Menchón JM (2015) Animal models of obsessive-compulsive disorder: utility and limitations. Neuropsychiatr Dis Treat 11:1939–1955 · DOI
  69. Grados M, Prazak M, Saif A, Halls A (2015) A review of animal models of obsessive-compulsive disorder: a focus on developmental, immune, endocrine and behavioral models. Expert Opin Drug Discov 11:27–43 · DOI
  70. Leone D, Gilardi D, Corrò BE, Menichetti J, Vegni E, Correale C et al (2019) Psychological characteristics of inflammatory bowel disease patients: a comparison between active and nonactive patients. Inflamm Bowel Dis 25:1399–1407 · DOI · Paper page
  71. Hesse S, Stengler K, Regenthal R, Patt M, Becker GA, Franke A et al (2011) The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder. Int J Neuropsychopharmacol 14:606–617 · DOI · Paper page
  72. Pittenger C, Adams TG Jr, Gallezot JD, Crowley MJ, Nabulsi N, James R et al (2016) OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding. J Affect Disord 196:87–96 · DOI · Paper page
  73. Akkus F, Terbeck S, Ametamey SM, Rufer M, Treyer V, Burger C et al (2014) Metabotropic glutamate receptor 5 binding in patients with obsessive-compulsive disorder. Int J Neuropsychopharmacol 17:1915–1922 · DOI · Paper page
  74. Wong DF, Brasić JR, Singer HS, Schretlen DJ, Kuwabara H, Zhou Y et al (2008) Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology 33:1239–1251 · DOI · Paper page
  75. Matsumoto R, Ichise M, Ito H, Ando T, Takahashi H, Ikoma Y et al (2010) Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study. Neuroimage 49:121–126 · DOI · Paper page
  76. Konuk N, Tekin IO, Ozturk U, Atik L, Atasoy N, Bektas S et al (2007) Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder. Mediators Inflamm 2007:65704 · DOI · Paper page
  77. Cosco TD, Pillinger T, Emam H, Solmi M, Budhdeo S, Matthew Prina A et al (2019) Immune aberrations in obsessive-compulsive disorder: a systematic review and meta-analysis. Mol Neurobiol 56:4751–4759 · DOI
  78. Kumar A, Williams MT, Chugani HT (2015) Evaluation of basal ganglia and thalamic inflammation in children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection and tourette syndrome: a positron emission tomographic (PET) study using 11C-[R]-PK11195. J Child Neurol 30:749–756 · DOI · Paper page
  79. Attwells S, Setiawan E, Wilson AA, Rusjan PM, Mizrahi R, Miler L et al (2017) Inflammation in the neurocircuitry of obsessive-compulsive disorder. JAMA Psy 74 · DOI · Paper page
  80. Garabadu D, Kumar V (2019) Celecoxib potentiates the antianxiety and anticompulsive-like activity of fluoxetine against chronic unpredictable mild stress in experimental animals. Behav Pharmacol 30:251–259 · DOI
  81. Panizzutti B, Skvarc D, Lin S, Croce S, Meehan A, Bortolasci CC et al (2023) Minocycline as treatment for psychiatric and neurological conditions: a systematic review and meta-analysis. Int J Mol Sci 24 · DOI
  82. Costa DLC, Diniz JB, Requena G, Joaquim MA, Pittenger C, Bloch MH et al (2017) Randomized, double-blind, placebo-controlled trial of N-acetylcysteine augmentation for treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry 78:e766–e773 · DOI · Paper page
  83. von der Warth R, Dams J, Grochtdreis T, König HH (2020) Economic evaluations and cost analyses in posttraumatic stress disorder: a systematic review. Eur J Psychotraumatol 11:1753940 · DOI · Paper page
  84. Sun Y, Qu Y, Zhu J (2021) The relationship between inflammation and post-traumatic stress disorder. Front Psychiatry 12 · DOI
  85. Zuo C, Zhuang Z, Yang P, Zhang H, Li X, Huang T et al (2023) Dissecting the causal association between inflammation and post-traumatic stress disorder: a bidirectional Mendelian randomization study. J Affect Disord 333:436–445 · DOI
  86. Smith KL, Kassem MS, Clarke DJ, Kuligowski MP, Bedoya-Pérez MA, Todd SM et al (2019) Microglial cell hyper-ramification and neuronal dendritic spine loss in the hippocampus and medial prefrontal cortex in a mouse model of PTSD. Brain Behav Immun 80:889–899 · DOI · Paper page
  87. Chaaya N, Wang J, Jacques A, Beecher K, Chaaya M, Battle AR et al (2021) Contextual fear memory maintenance changes expression of pMAPK, BDNF and IBA-1 in the pre-limbic cortex in a layer-specific manner. Front Neural Circuits 15:660199 · DOI
  88. Kao CY, He Z, Zannas AS, Hahn O, Kühne C, Reichel JM et al (2016) Fluoxetine treatment prevents the inflammatory response in a mouse model of posttraumatic stress disorder. J Psychiatr Res 76:74–83 · DOI
  89. Bhatt S, Hillmer AT, Girgenti MJ, Rusowicz A, Kapinos M, Nabulsi N et al (2020) PTSD is associated with neuroimmune suppression: evidence from PET imaging and postmortem transcriptomic studies. Nat Commun 11 · DOI
  90. Bonomi R, Hillmer AT, Woodcock E, Bhatt S, Rusowicz A, Angarita GA et al (2024) Microglia-mediated neuroimmune suppression in PTSD is associated with anhedonia. Proc Natl Acad Sci U S A 121:e2406005121 · DOI
  91. Deri Y, Clouston SAP, DeLorenzo C, Gardus JD, Bartlett EA, Santiago-Michels S et al (2021) Neuroinflammation in World Trade Center responders at midlife: a pilot study using [18F]-FEPPA PET imaging. Brain Behav Immun Health 16 · DOI
  92. Seo S, Jung YH, Lee D, Lee WJ, Jang JH, Lee JY et al (2021) Abnormal neuroinflammation in fibromyalgia and CRPS using [11C]-(R)-PK11195 PET. PLoS ONE 16:e0246152 · DOI · Paper page
  93. Watling SE, Gill T, Gaudette EV, Richardson JD, McCluskey T, Tong J et al (2023) Investigating TSPO levels in occupation-related posttraumatic stress disorder. Sci Rep 13 · DOI
  94. Lee B, Sur B, Yeom M, Shim I, Lee H, Hahm DH (2016) Effects of systemic administration of ibuprofen on stress response in a rat model of post-traumatic stress disorder. Korean J Physiol Pharmacol 20:357–366 · DOI · Paper page
  95. Patankar PS, Joshi S, Mane A, Manjesh PS, Kokate D (2021) Anxiolytic effect of minocycline in posttraumatic stress disorder model of Syrian hamsters. Tzu Chi Med J 33:263–269 · DOI
  96. Qiu ZK, Zhang LM, Zhao N, Chen HX, Zhang YZ, Liu YQ et al (2013) Repeated administration of AC-5216, a ligand for the 18 kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 45:40–46 · DOI
  97. Shang C, Guo Y, Yao JQ, Fang XX, Sun LJ, Jiang XY et al (2020) Rapid anti-PTSD-like activity of the TSPO agonist YL-IPA08: emphasis on brain GABA, neurosteroids and HPA axis function. Behav Brain Res 379:112320 · DOI
  98. Qiu Z-K, Liu X, Chen Y, Wu R-J, Guan S-F, Pan Y-y et al (2020) Translocator protein 18 kDa: a potential therapeutic biomarker for post traumatic stress disorder. Metab Brain Dis 35:695–707 · DOI
  99. Lv H, Guo M, Guo C, He K (2024) The interrelationships between cytokines and schizophrenia: a systematic review. Int J Mol Sci 25 · doi:10.37766/inplasy2024.7.0128
  100. Williams JA, Burgess S, Suckling J, Lalousis PA, Batool F, Griffiths SL et al (2022) Inflammation and brain structure in schizophrenia and other neuropsychiatric disorders: a Mendelian randomization study. JAMA Psychiat 79:498–507 · DOI · Paper page
  101. Notter T, Coughlin JM, Gschwind T, Weber-Stadlbauer U, Wang Y, Kassiou M et al (2018) Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia. Mol Psychiatry 23:323–334 · DOI · Paper page
  102. Kenk M, Selvanathan T, Rao N, Suridjan I, Rusjan P, Remington G et al (2015) Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA. Schizophr Bull 41:85–93 · DOI · Paper page
  103. Collste K, Plavén-Sigray P, Fatouros-Bergman H, Victorsson P, Schain M, Forsberg A et al (2017) Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [(11)C]PBR28. Mol Psychiatry 22:850–856 · DOI · Paper page
  104. Laurikainen H, Vuorela A, Toivonen A, Reinert-Hartwall L, Trontti K, Lindgren M et al (2020) Elevated serum chemokine CCL22 levels in first-episode psychosis: associations with symptoms, peripheral immune state and in vivo brain glial cell function. Transl Psychiatry 10:94 · DOI
  105. De Picker L, Ottoy J, Verhaeghe J, Deleye S, wyffels L, Fransen E et al (2019) State-associated changes in longitudinal [18F]-PBR111 TSPO PET imaging of psychosis patients: evidence for the accelerated ageing hypothesis? Brain Behav Immun 77:46–54 · DOI
  106. Ottoy J, De Picker L, Verhaeghe J, Deleye S, wyffels L, Kosten L et al (2018) 18F-PBR111 PET imaging in healthy controls and schizophrenia: test–retest reproducibility and quantification of neuroinflammation. J Nucl Med 59:1267–74 · DOI
  107. Bloomfield PS, Selvaraj S, Veronese M, Rizzo G, Bertoldo A, Owen DR et al (2016) Microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [11C]PBR28 PET brain imaging study. Am J Psychiatry 173:44–52 · DOI · Paper page
  108. Hafizi S, Tseng H-H, Rao N, Selvanathan T, Kenk M, Bazinet RP et al (2017) Imaging microglial activation in untreated first-episode psychosis: a PET study with [18F]FEPPA. Am J Psychiatry 174:118–124 · DOI · Paper page
  109. Coughlin JM, Wang Y, Ambinder EB, Ward RE, Minn I, Vranesic M et al (2016) In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma. Transl Psychiatry 6:e777 · DOI · Paper page
  110. Hafizi S, Da Silva T, Meyer JH, Kiang M, Houle S, Remington G et al (2018) Interaction between TSPO—a neuroimmune marker—and redox status in clinical high risk for psychosis: a PET–MRS study. Neuropsychopharmacology 43:1700–1705 · DOI
  111. Kenk M, Selvanathan T, Rao N, Suridjan I, Rusjan P, Remington G et al (2014) Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA. Schizophr Bull 41:85–93 · DOI · Paper page
  112. Hafizi S, Da Silva T, Gerritsen C, Kiang M, Bagby RM, Prce I et al (2017) Imaging microglial activation in individuals at clinical high risk for psychosis: an in vivo PET study with [(18)F]FEPPA. Neuropsychopharmacology 42:2474–2481 · DOI
  113. Doorduin J, de Vries EF, Willemsen AT, de Groot JC, Dierckx RA, Klein HC (2009) Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med 50:1801–1807 · DOI · Paper page
  114. Banati R, Hickie IB (2009) Therapeutic signposts: using biomarkers to guide better treatment of schizophrenia and other psychotic disorders. Med J Aust 190:S26-32 · DOI · Paper page
  115. van Berckel BN, Bossong MG, Boellaard R, Kloet R, Schuitemaker A, Caspers E et al (2008) Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry 64:820–822 · DOI · Paper page
  116. Conen S, Gregory CJ, Hinz R, Smallman R, Corsi-Zuelli F, Deakin B et al (2021) Neuroinflammation as measured by positron emission tomography in patients with recent onset and established schizophrenia: implications for immune pathogenesis. Mol Psychiatry 26:5398–5406 · DOI
  117. Takano A, Arakawa R, Ito H, Tateno A, Takahashi H, Matsumoto R et al (2010) Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106. Int J Neuropsychopharmacol 13:943–950 · DOI · Paper page
  118. van der Doef TF, de Witte LD, Sutterland AL, Jobse E, Yaqub M, Boellaard R et al (2016) In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis. NPJ Schizophr 2:16031 · DOI · Paper page
  119. Di Biase MA, Zalesky A, O’Keefe G, Laskaris L, Baune BT, Weickert CS et al (2017) PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia. Transl Psychiatry 7:e1225 · DOI
  120. Holmes SE, Hinz R, Drake RJ, Gregory CJ, Conen S, Matthews JC et al (2016) In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [(11)C](R)-PK11195 positron emission tomography study. Mol Psychiatry 21:1672–1679 · DOI
  121. Plavén-Sigray P, Matheson GJ, Collste K, Ashok AH, Coughlin JM, Howes OD et al (2018) Positron emission tomography studies of the glial cell marker translocator protein in patients with psychosis: a meta-analysis using individual participant data. Biol Psychiatry 84:433–442 · DOI · Paper page
  122. Manji H, Kato T, Di Prospero NA, Ness S, Beal MF, Krams M et al (2012) Impaired mitochondrial function in psychiatric disorders. Nat Rev Neurosci 13:293–307 · DOI · Paper page
  123. Roberts RC (2017) Postmortem studies on mitochondria in schizophrenia. Schizophr Res 187:17–25 · DOI
  124. Somerville SM, Conley RR, Roberts RC (2011) Mitochondria in the striatum of subjects with schizophrenia. World J Biol Psychiatry 12:48–56 · DOI
  125. Nitta M, Kishimoto T, Müller N, Weiser M, Davidson M, Kane JM et al (2013) Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials. Schizophr Bull 39:1230–1241 · DOI · Paper page
  126. Nozaki K, Ito H, Ohgidani M, Yamawaki Y, Sahin EH, Kitajima T et al (2020) Antidepressant effect of the translocator protein antagonist ONO-2952 on mouse behaviors under chronic social defeat stress. Neuropharmacology 162 · DOI

Metadata

Authors
Liu, Y.-D., Chang, Y.-H., Xie, X.-T., Wang, X.-Y., Ma, H.-Y., Liu, M.-C., & Zhang, H.-M.
Venue
Molecular Neurobiology
Published
2025-07-04
Volume
62
Issue
12
Pages
15318-15335
ISSN
  • 0893-7648
  • 1559-1182
Cited by
27
References
21
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PET Imaging Unveils Neuroinflammatory Mechanisms in Psychiatric Disorders: From Microglial Activation to Therapeutic Innovation. https://app.cochat.ai/papers/10.1007/s12035-025-05177-w
The paper
Liu, Y.-D., Chang, Y.-H., Xie, X.-T., Wang, X.-Y., Ma, H.-Y., Liu, M.-C., & Zhang, H.-M. (2025). PET Imaging Unveils Neuroinflammatory Mechanisms in Psychiatric Disorders: From Microglial Activation to Therapeutic Innovation. Molecular Neurobiology. https://doi.org/10.1007/s12035-025-05177-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.